Phase 1 Clinical Trial Met All Primary and Secondary Endpoints and Demonstrated Positive Safety, Pharmacokinetics, and ...

Neutrophils are the most abundant immune cells in the body and the first to respond to infection or tissue damage. Yet ...

A newly developed compound that reduces harmful inflammation in rats caused by overactive neutrophils shows great potential as a safer treatment for various inflammatory diseases in humans.

A newly developed compound that reduces harmful inflammation in rats caused by overactive neutrophils shows great potential as a safer treatment for various inflammatory diseases in humans.

Researchers at Yale University School of Medicine have identified a way to suppress the daily fluctuations in the activity of ...

Heart attacks that occur at night are less severe than those that strike during the day. A new study from the Centro Nacional ...

Published in the Journal of Experimental Medicine, the study is one of the first to harness the circadian rhythms of the immune system to modulate inflammation without compromising defense against inf ...

Known for their role in allergic reactions, mast cells have long been recognised as key players in our immune system. When they encounter allergens, they release chemicals that trigger typical allergy ...

Newton Biocapital enters as new investor, strong participation of existing investorsPivotal Phase 2b trial initiation in 2027 of BIOX-101 to ...